Kimberly C Pham, OD
Optometry · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pham’s office at (916) 688-2000 to ask if they take your plan before you enroll.
Medicaid work
$99,817 in 2024
Medicaid paid $99,817 for 1,306 billed services this clinician did in 2024, up to 71 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 384 | $63,363 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 189 | $19,895 |
| DETERMINATION REFRACTIVE STATE | 689 | $13,968 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 31 | $1,934 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 13 | $657 |
| 2024 | 1,306 | 5 | 71 | $99,817 |
| 2023 | 1,628 | 7 | 84 | $97,154 |
| 2022 | 470 | 5 | 73 | $14,766 |
| 2019 | 14 | 1 | 13 | $477 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 349 | $48,759 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 297 | $32,736 |
| DETERMINATION REFRACTIVE STATE | 773 | $14,072 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 28 | $1,587 |
| Frames, purchases | 101 | $0 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 24 | $0 |
| Anti-reflective coating, per lens | 56 | $0 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 103 | $10,055 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 87 | $2,541 |
| DETERMINATION REFRACTIVE STATE | 213 | $2,170 |
| Frames, purchases | 36 | $0 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 31 | $0 |
2019
| Service | 14 | $477 |
Drugs they prescribed that Part D paid
$7,607
Pharmacies billed $7,607 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 135) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
94 generic and 41 brand-name prescriptions · $7,607 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 21 | $1,922 | $92 |
| Latanoprost | 51 | $827 | $16 |
| Prednisolone Acetate | 12 | $594 | $49 |
| Timolol Maleate | 12 | $166 | $14 |
Year by year
| 2024 | 135 | 71 | 0% (0) | 30% | $7,607 |
| 2023 | 117 | 71 | 0% (0) | 29% | $7,171 |
| 2022 | 448 | 147 | None | 51% | $71,657 |
| 2021 | 429 | 149 | 0% (0) | 55% | $77,580 |
| 2020 | 387 | 159 | 0% (0) | 53% | $65,821 |
| 2019 | 316 | 106 | 0% (0) | 47% | $23,829 |
| 2018 | 271 | 90 | 0% (0) | 57% | $18,028 |
| 2017 | 268 | 84 | 0% (0) | 51% | $17,592 |
| 2016 | 25 | 17 | 0% (0) | 44% | $1,884 |
| 2015 | 15 | None | 0% (0) | None | $1,614 |
| 2014 | 57 | None | 0% (0) | None | $5,463 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cyclosporine | 15 | $1,577 | $105 |
| Latanoprost | 48 | $1,258 | $26 |
2022: 6 drugs
| Latanoprost | 188 | $7,619 | $41 |
| Lumigan | 11 | $6,564 | $597 |
| Brimonidine | 18 | $3,351 | $186 |
| Dorzolamide-Timolol | 53 | $2,592 | $49 |
| Prednisolone Acetate | 20 | $1,030 | $52 |
| Timolol Maleate | 45 | $545 | $12 |
2021: 8 drugs
| Combigan | 26 | $11,980 | $461 |
| Latanoprost | 161 | $5,522 | $34 |
| Brimonidine | 15 | $4,026 | $268 |
| Timolol Maleate | 45 | $3,347 | $74 |
| Dorzolamide-Timolol | 42 | $1,877 | $45 |
| Prednisolone Acetate | 21 | $1,194 | $57 |
| Dorzolamide | 12 | $568 | $47 |
| Neomycin-Polymyxin-Dexameth | 11 | $177 | $16 |
2020: 8 drugs
| Restasis | 21 | $23,562 | $1,122 |
| Xiidra | 17 | $12,530 | $737 |
| Rhopressa | 11 | $4,818 | $438 |
| Latanoprost | 141 | $4,257 | $30 |
| Brimonidine | 20 | $2,383 | $119 |
| Dorzolamide-Timolol | 31 | $2,370 | $76 |
| Prednisolone Acetate | 25 | $980 | $39 |
| Timolol Maleate | 30 | $537 | $18 |
2019: 6 drugs
| Brimonidine | 25 | $4,607 | $184 |
| Latanoprost | 148 | $4,505 | $30 |
| Prednisolone Acetate | 13 | $905 | $70 |
| Dorzolamide | 15 | $739 | $49 |
| Timolol Maleate | 50 | $712 | $14 |
| Atropine Sulfate | 12 | $580 | $48 |
2018: 5 drugs
| Latanoprost | 114 | $3,447 | $30 |
| Brimonidine | 33 | $2,894 | $88 |
| Timolol Maleate | 52 | $1,099 | $21 |
| Prednisolone Acetate | 14 | $824 | $59 |
| Dorzolamide | 12 | $407 | $34 |
2017: 7 drugs
| Acetazolamide | 12 | $3,015 | $251 |
| Latanoprost | 86 | $1,858 | $22 |
| Cosopt Pf | 11 | $1,683 | $153 |
| Brimonidine | 33 | $1,316 | $40 |
| Prednisolone Acetate | 17 | $957 | $56 |
| Dorzolamide | 24 | $663 | $28 |
| Timolol Maleate | 40 | $505 | $13 |
2014: 1 drug
| Metformin | 13 | $135 | $10 |
Money from drug and device companies
$84 in 2025
| 2025 | 1 | 1 | None | $84 |
| 2024 | 2 | 2 | None | $152 |
| 2022 | 3 | 3 | None | $61 |
| 2021 | 1 | 2 | None | $50 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CooperVision | Myday Contact Lens | $84 | 1 payment
|
See the published payment
| CooperVision | Meals · 2025-11-21 | Myday Contact Lens | $84 |
See earlier years (2024, 2022, 2021)
2024: $152
| Bausch & Lomb Americas | Infuse Multifocal | $125 | 1 payment
|
| Astellas Pharma US | Izervay | $26 | 1 payment
|
2022: $61
| Oyster Point Pharma | Tyrvaya | $23 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $21 | 1 payment
|
| Allergan | Vuity | $17 | 1 payment
|
2021: $50
| Allergan | Lumigan | $50 | 2 payments
|
Professional record
- NPI
- 1023351806
- Trained
- Southern California College of Optometry, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 1522 Meadow Glen Way, San Jose, CA, 95121
- NPI first listed
- 2013-03-31
- NPI last updated
- 2022-10-25
- NPI record certified
- 2022-10-25
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.